reports
Esperion Announces Pricing of Public Offering of Common Stock
Esperion Announces Pricing of Public Offering of Common Stock ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C), today announced the pricing of an underwritten public offering of 30,000,000 shares of its common stock at a public offering price of $2.50 per share. In addition, Esperion has granted the underwrit...
Piedmont Realty Trust, Inc. to Report Third Quarter 2025 Financial Res...
Piedmont Realty Trust, Inc. to Report Third Quarter 2025 Financial Results Atlanta, GA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Piedmont Realty Trust (NYSE: PDM) announced today that the Company will release its third quarter financial results on Monday, October 27, 2025, after the close of trading on the New York Stock Exchange. A conference call is scheduled for Tuesday, October 28, 2025, at 9:00 a.m. ET and will be broadcast live in listen-only mode on the company’s investor relations website. During the conference call, the Company’s management team will review third quarter performance, di...
Esperion Announces Proposed Public Offering of Common Stock
Esperion Announces Proposed Public Offering of Common Stock ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C), today announced that it has commenced an underwritten public offering of shares of its common stock. Esperion also intends to grant the underwriters a 30-day option to purchase up to an additional fif...
Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Lab...
Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040 ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories, Inc. and its affiliate Dr. Reddy’s Laboratories Ltd. (together, Dr. Reddy’s Laboratories). This agreement resolves the patent litigation brought by Esperion against Dr. Reddy’s Laboratories in response to Dr. Redd...
American Assets Trust, Inc. Announces Third Quarter 2025 Earnings Rele...
American Assets Trust, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Information SAN DIEGO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its third quarter 2025 earnings in a press release to be issued after the market closes on Tuesday, October 28, 2025. Senior management will hold a conference call for its third quarter 2025 earnings on Wednesday, October 29, 2025 at 8:00 a.m. Pacific Time (“PT”). To access the conference call, please dial 1 (833) 816-1162 and ask to join the American Assets Trust,...
Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETO...
Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL® in Japan for the Treatment of Hypercholesterolemia Third Largest Global Market for Cardiovascular Prevention Represents Significant Global Growth Opportunity for NEXLETOL ANN ARBOR, Mich., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka), the Company’s partner for the development and commercialization of NEXLETOL® (bempedoic acid) tablets in Japan, has received approval from the Japanese Ministry of Health, Labour and Welfare to market NEXLETOL...
Veritex Holdings Inc: 1 director
A director at Veritex Holdings Inc sold 2,203 shares at 34.352USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Piedmont Realty Trust, Inc. Signs over 500,000 SF of Leases Third Quar...
Piedmont Realty Trust, Inc. Signs over 500,000 SF of Leases Third Quarter-to-Date Bringing Year to Date Leasing to over 1.5 million Square Feet Atlanta, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Piedmont Realty Trust, Inc. ("Piedmont” or “the Company") (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, announced today, that the Company is participating in this week’s Bank of America Securities 2025 Global Real Estate Conference in New York. The Company has completed over 500,000 square feet of leasing thus far in the third quarter, with over 400,000 square feet r...
Spok Holdings Inc: 1 director
A director at Spok Holdings Inc sold 38,008 shares at 18.085USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Veritex Holdings, Inc. Declares Cash Dividend on Common Stock
Veritex Holdings, Inc. Declares Cash Dividend on Common Stock DALLAS, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or the “Company”), the parent holding company for Veritex Community Bank, today announced the declaration of a cash dividend of $0.22 per share on its outstanding common stock. The dividend will be paid on or after September 30, 2025 to shareholders of record as of September 16, 2025. About Veritex Holdings, Inc. Headquartered in Dallas, Texas, Veritex is a bank holding company that conducts banking activities through its wholly-owned...
Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ...
Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias – Bempedoic Acid Receives Strongest Endorsement from ESC/EAS Guidelines Based on Compelling and Practice-Changing Evidence – – Guideline Recognition of ‘Strike Early and Strike Strong’ Approach with Early Combination Lipid-Lowering Therapy Affirms Continued Development of Company’s Oral Triple Combination Therapies in U.S. – ANN ARBOR, Mich., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today welcomed the inclusion of bempedoic acid as the only n...
Esperion to Participate in Upcoming September Investor Conferences
Esperion to Participate in Upcoming September Investor Conferences ANN ARBOR, Mich., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of September, which can be found on our investor relations . Cantor Global Healthcare Conference in New York on September 3, 2025, at 9:45 a.m. ET. H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8, 2025, at 2:00 p.m. ET. Live webcasts can be accessed on the investor and media section of the Esperio...
Cincinnati Financial Corp: 1 director
A director at Cincinnati Financial Corp sold 3,500 shares at 153.544USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)...
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ANN ARBOR, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on August 5, 2025, the Company granted 12 new employees 73,500 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such indivi...
Esperion Reports Second Quarter 2025 Financial Results and Provides Bu...
Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update – Q2 2025 Total Revenue Grew 12% Y/Y to $82.4 Million – – Q2 2025 U.S. Net Product Revenue Grew 42% Y/Y to $40.3 Million – – Total Retail Prescription Equivalents Increased 10% from First Quarter – – Reached Settlement Agreements with Three ANDA Filers Not to Market Generic Versions of NEXLETOL® (bempedoic acid) Prior to 2040 – – First Quarter of Operating Income from Ongoing Business with Plans for Sustainable Profitability Starting in Q1 2026 – – Conference Call and Webcast Today at 8:00 a.m...
American Assets Trust, Inc. Reports Second Quarter 2025 Financial Resu...
American Assets Trust, Inc. Reports Second Quarter 2025 Financial Results Net income available to common stockholders of $5.5 million and $48.0 million for the three and six months ended June 30, 2025, respectively, or $0.09 and $0.79 per diluted share, respectively. Funds from Operations ("FFO") excluding lease termination fees and litigation income of $0.51 and $1.03 per diluted share for the three and six months ended June 30, 2025, respectively, compared to $0.60 and $1.19 per diluted share for the same periods in 2024. Increased 2025 FFO per diluted share guidance to a range of ...
Piedmont Realty Trust, Inc. Releases Second Quarter 2025 Results
Piedmont Realty Trust, Inc. Releases Second Quarter 2025 Results Atlanta, GA, July 28, 2025 (GLOBE NEWSWIRE) -- Piedmont Realty Trust (NYSE: PDM) has released its financial and operational results for the second quarter of 2025. Please visit the Investor Relations section of Piedmont's website at to access the Earnings Release and Supplemental Information. Piedmont has scheduled a conference call and an an audio web cast for Tuesday, July 29, 2025, at 9:00 a.m. ET during which the Company’s management team will review second quarter performance, discuss recent events, and conduct a que...
Esperion to Report Second Quarter 2025 Financial Results on August 5
Esperion to Report Second Quarter 2025 Financial Results on August 5 ANN ARBOR, Mich., July 22, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2025 financial results before the market opens on Tuesday, August 5, 2025. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion . Access to the webcast replay will be available approximately two hours after completion of the call and...
Veritex Holdings, Inc. Reports Second Quarter 2025 Operating Results a...
Veritex Holdings, Inc. Reports Second Quarter 2025 Operating Results and Declares Quarterly Dividend DALLAS, July 18, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (“Veritex”, the “Company”, “we” or “our”) (Nasdaq: VBTX), the holding company for Veritex Community Bank, today announced the results for the quarter ended June 30, 2025. The Company also announced that the Board of Directors declared a quarterly cash dividend of $0.22 per share of common stock. The dividend will be payable on August 21, 2025 to shareholders of record as of the close of business on August 7, 2025. Quarter...
Veritex Holdings, Inc. Announces Date Change for Second Quarter 2025 E...
Veritex Holdings, Inc. Announces Date Change for Second Quarter 2025 Earnings Release and Cancellation of Conference Call DALLAS, July 15, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX), the parent holding company for Veritex Community Bank, today announced a date change for release of its second quarter 2025 earnings results. Veritex will now release its second quarter 2025 earnings results before the opening of the market on Friday, July 18, 2025. The earnings release will be available on Veritex’s website, . Veritex also announced the cancellation of its second quart...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.